Mechanisms and Mediators of Inflammation: Potential Models for Skin Rejection and Targeted Therapy in Vascularized Composite Allotransplantation
Open Access
- 19 September 2012
- journal article
- review article
- Published by Wiley in Journal of Immunology Research
- Vol. 2012, 1-9
Abstract
Vascularized composite allotransplantation (VCA) is an effective treatment option for patients suffering from limb loss or severe disfigurement. However, postoperative courses of VCA recipients have been complicated by skin rejection, and long-term immunosuppression remains a necessity for allograft survival. To widen the scope of this quality-of-life improving procedure minimization of immunosuppression in order to limit risks and side effects is needed. In some aspects, the molecular mechanisms and dynamics of skin allograft rejection seem similar to inflammatory skin conditions. T cells are key players in skin rejection and are recruited to the skin via activation of adhesion molecules, cytokines, and chemokines. Blocking these molecules has not only shown success in the treatment of inflammatory dermatoses, but also prolonged graft survival in various models of solid organ transplantation. In addition to T cell recruitment, ectopic lymphoid structures within the allograft associated with chronic rejection in solid organ transplantation might contribute to the strong alloimmune response towards the skin. Selectively targeting the molecules involved offers exciting novel therapeutic options in the prevention and treatment of skin rejection after VCA.Keywords
This publication has 124 references indexed in Scilit:
- Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responsesThe FASEB Journal, 2011
- Recent advances in immunosuppressive therapy for prevention of renal allograft rejectionCurrent Opinion in Organ Transplantation, 2011
- LFA-1 Antagonism Inhibits Early Infiltration of Endogenous Memory CD8 T Cells into Cardiac Allografts and Donor-Reactive T Cell PrimingAmerican Journal of Transplantation, 2011
- rPSGL-Ig for Improvement of Early Liver Allograft Function: A Double-Blind, Placebo-Controlled, Single-Center Phase II Study†American Journal of Transplantation, 2011
- Chemokines and Their Receptors in Human Renal AllotransplantationTransplantation, 2011
- LFA-1–specific therapy prolongs allograft survival in rhesus macaquesJournal of Clinical Investigation, 2010
- The innate immune response in ischemic acute kidney injuryClinical Immunology, 2009
- Ectopic lymphoid tissues and local immunitySeminars in Immunology, 2008
- Cell adhesion and polarity during immune interactionsImmunological Reviews, 2002
- Role of ICAM-3 in the initial interaction of T lymphocytes and APCsNature Immunology, 2002